Zelda Therapeutics to use Federal Government R&ampD tax rebate of $769000 to drive clinical trials

[ad_1]

&#8230 in breast, brain and pancreatic cancer as effectively as investigation examining the prospective for cannabinoids to treat diabetes-connected cognitive decline. Study Much more

The post Zelda Therapeutics to use Federal Government R&#038D tax rebate of $769000 to drive clinical trials appeared very first on Dagga Magazine.

[ad_2]

Latest posts